Related Experiment Video
Updated: Dec 7, 2025

Genome Engineering of Primary Human B Cells Using CRISPR/Cas9
Published on: November 3, 2020
Easy and robust electrotransfection protocol for efficient ectopic gene expression and genome editing in human B
Reynand Jay Canoy1,2, Franck André1, Anna Shmakova1,3
1UMR 9018, CNRS, Univ. Paris-Sud, Université Paris Saclay, Institut Gustave Roussy, 94805, Villejuif, France.
Abstract:
B-cell lines and primary PBMCs are notoriously hard to transfect, thus making genome editing, ectopic gene expression, or gene silencing experiments particularly tedious. Here we propose a novel efficient and reproducible protocol for electrotransfection of lymphoblastoid, B-cell lymphoma, leukemia cell lines, and B cells from PBMCs. The proposed protocol requires neither costly equipment nor expensive reagents; it can be used with small or large plasmids. Transfection and viability rates of about 79% and 58%, respectively, have been routinely achieved by optimizing the salt concentration in the electrotransfection medium and the amount of plasmid used. A validation of the protocol was obtained via the generation of a TP53-/- RPMI8866 lymphoblastoid cell line which should prove useful in future hematological and blood cancer studies.

